My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

VanEck Morningstar Wide Moat Value ETF (NY:MVAL)

38.99 UNCHANGED

Streaming Delayed Price Updated: 8:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VanEck Morningstar Wide Moat Value ETF

Nike's Turnaround Story Shows Momentum, But Can They Counter China? ↗

October 06, 2025

B Of A analyst maintains Buy rating on Nike, with $84 price target after strong Q1 earnings. Sales recovery boosts confidence in turnaround.

Via Benzinga

Campbell's CEO Highlights Brand Strength But Warns Tariffs Will Dent Profits ↗

September 03, 2025

The Campbell's Company (CPB) trading higher in premarket despite mixed fourth-quarter report with sales growth of 1%, beating EPS estimates.

Via Benzinga

IFF Joins Forces With Kemira For Joint Venture Focused On Biopolymer Production ↗

March 27, 2025

IFF shares up on joint venture with Kemira to produce sustainable biobased materials in Finland, using IFF's DEB platform technology.

Via Benzinga

Kim Kardashian's SKIMS Joins Forces With Nike For Fitness Fashion, Stock Gains ↗

February 18, 2025

Nike and Kim Kardashian's SKIMS have launched NikeSKIMS, a new activewear brand focused on innovation and inclusivity for women athletes.

Via Benzinga

Nike, NBA Extend Apparel And Content Partnership For 12 More Years ↗

October 22, 2024

Nike has been a partner of the NBA since 1992, a marketing partner of the WNBA since 1997, and a G League partner since 2017.

Via Benzinga

VanEck Announces Year-End Distributions for VanEck Equity ETFs

December 20, 2024

From VanEck

Via Business Wire

Nike Upgraded: Analyst Optimistic Despite Lengthy Process And Competitive Challenges ↗

October 10, 2024

Truist Securities analyst upgrades Nike to Buy with $97 price target, citing improved leadership, marketing, and wholesale relationships for a potential turnaround.

Via Benzinga

IFF's Leverage to Improve by 2025, Sales Momentum to Boost EBITDA, Projects Analyst ↗

July 22, 2024

IFF stock upgraded to Buy with increased price target of $115. Analyst sees sales and EBITDA growth, expects leverage to decrease and Q2 results on Aug 6.

Via Benzinga

IFF's Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst ↗

June 07, 2024

Oppenheimer initiates coverage on IFF at Outperform rating with $116 price target. Analyst sees potential for shareholder base shift and ongoing growth. Estimated EPS of $3.94 in FY24, $4.28 in FY25,...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.